Cart
sales@molnova.com
Phenylbutazone
CAS No. 50-33-9
Phenylbutazone( Phenylbutazone | Fenilbutazona | Diphenylbutazone | Butapyrazole | Phenylbutazonum )
Catalog No. M14704 CAS No. 50-33-9
Phenylbutazone(Butazolidin, Butatron) is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 45 | In Stock |
|
| 1G | 60 | In Stock |
|
Biological Information
-
Product NamePhenylbutazone
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenylbutazone(Butazolidin, Butatron) is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis.
-
DescriptionPhenylbutazone(Butazolidin, Butatron) is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis. Its use is limited by such severe side effects as suppression of white blood cell production and aplastic anemia. (In Vitro):Phenylbutazone has low inhibition of COX-1 and COX-2.
-
In VitroPhenylbutazone has low inhibition of COX-1 and COX-2.
-
In Vivo——
-
SynonymsPhenylbutazone | Fenilbutazona | Diphenylbutazone | Butapyrazole | Phenylbutazonum
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number50-33-9
-
Formula Weight308.38
-
Molecular FormulaC19H20N2O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 62 mg/mL (201.05 mM); DMSO: 62 mg/mL (201.05 mM)
-
SMILESCCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
-
Chemical Name4-butyl-1,2-diphenylpyrazolidine-3,5-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arifah AK, Lees P. J Vet Pharmacol Ther. 2002 Aug;25(4):299-309.
molnova catalog
related products
-
Indomethacin sodium ...
Indomethacin sodium hydrate (Indometacin sodium hydrate) is an orally active, competitive and reversible COX1/2 inhibitor with potential anti-inflammatory activity in induced migraines.
-
Gadodiamide
Gadodiamide, a nonionic Gd3+ chelate, is frequently injected i.v. into magnetic resonance imaging (MRI) to enhance contrast.
-
Etoricoxib
Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).
